I. Latorre (Badalona, Spain), M. Eisenhut (Luton, United Kingdom), M. Aabye (Hvidovre, Denmark)
Within-subject variability of tuberculosis immune responses in health care workers
F. C. Ringshausen, H. Knoop, S. Schlösser, G. Schultze-Werninghaus, G. Rohde, A. Nienhaus (Hamburg, Bochum, Germany; Maastricht, Netherlands)
|  |
Conversion and reversion rates in serial examination in German healthcare worker with the interferon-gamma release assay
A. Schablon, R. Diel, F. C. Ringshausen, A. Nienhaus (Hamburg, Hannover, Germany)
|  |
Specificity and negative predictive value of the QuantiFERON-TB®-Gold In Tube testing on trainees in healthcare settings
A. Schablon, G. Diner, U. Anske, A. Nienhaus (Hamburg, Berlin, Germany)
| |
Prevalence of LTBI using IGRA and TST in a cohort of health professional trainees from India
D. J. Christopher, P. James, J. Sarojini Michael, D. Shankar, A. Zwerling, M. Pai (Vellore, India; Montreal, Canada)
| |
Evaluation of latent tuberculosis infection in health care workers by QuantiFERON-TB Gold test and tuberculin skin test
D. Yenibertiz, D. Kanmaz, B. Yilmaz, F. Atabey, E. Tuncay (Istanbul, Turkey)
| |
Serial testing using IGRAs in a cohort of Indian nursing students
D. J. Christopher, P. James, J. Sarojini Michael, A. Zwerling, M. Pai (Vellore, India; Montreal, Canada)
| |
Tuberculosis screening program using the QuantiFERON-TB Gold test and chest computed tomography for healthcare workers accidentally exposed to patients with tuberculosis
T. Hirama, K. Hagiwara, M. Kanazawa (Moroyama, Japan)
| |
The additional diagnostic value of interferon gamma release assay to the tuberculin skin test in Greek health care workers (a preliminary study)
A. Charisis, A. Konstantinidis, C. Gartzonika, D. Archimandriti, A. Gogali, C. Katsanos, A. Kostoulas, S. Katsenos, G. Daskalopoulos, S. Leveidiotou-Stefanou, A. Mavridis, S. Constantopoulos (Ioannina, Greece)
| |
Concordance between IGRA and TST in a cohort of health professional trainees from India
D. J. Christopher, P. James, J. Sarojini Michael, A. Zwerling, M. Pai (Vellore, India; Montreal, Canada)
| |
IGRA testing correlation with clinical and laboratory parameters in patients with tuberculosis
J. Kotrbova, M. Vasakova, J. Homolka, E. Kopecka, J. Skibova (Prague, Czech Republic)
| |
Useful of Quantiferon G in managing solitary pulmonary nodule of less than 3 cm
S. Saenghirunvattana, K. Saenghirunvattana, P. Masakul, C. Vinitwatanakhun (Bangkok, Thailand)
| |
T spot TB – Changing trends and resource implications for trusts
M. Patel, A. Morris, B. Prathibha (Ashford, United Kingdom)
| |
Clinical utility of the interferon-gamma for the diagnosis of active pulmonary tuberculosis
S. Kasikovic Lecic, S. Pavlovic, V. Kuruc, M. Ilic, D. Kukavica (Sremska Kamenica, Republic Of Serbia)
| |
Unfavorable factors associated with false negative results of interferon-gamma release assay for tuberculosis
N. T. L. Hang, L. T. Lien, N. Kobayashi, T. Shimbo, S. Sakurada, P. H. Thuong, L. T. Hong, D. B. Tam, M. Hijikata, I. Matsushita, N. V. Hung, K. Higuchi, N. Harada, N. Keicho (Hanoi, Viet Nam; Tokyo, Japan)
| |
The influence of a high negative control on the interpretation of QuantiFERON Gold in Tube (QFN) results
W. Ricketts, G. Bothamley (London, United Kingdom)
| |
Clinical history and IGRA is unreliable in the diagnosis of tuberculosis
W. Ricketts, G. Bothamley (London, United Kingdom)
| |
Specificity of IRGAs in Japan
K. Higuchi, Y. Sekiya, H. Igari, A. Watanabe, N. Harada (Kiyose, Chiba-shi, Japan)
| |
Do kinetics of interferon-gamma responses predict TB relapse?
C. Chee, K. W. KhinMar, S. H. Gan, T. Barkham, Y. T. Wang (Singapore, Singapore)
| |
Necessity of re-centrifugation of QuantiFERON®-TB Gold In-Tube samples after plasma harvest
N. Harada, K. Higuchi, Y. Sekiya (Kiyose, Japan)
| |
Accuracy of IFN-γ and IP-10 detection for diagnosis of tuberculosis in children
I. Latorre, J. Diez, I. Mialdea, N. Altet, C. Prat, N. Diez, A. Escribano, M. Ruhwald, V. Ausina, J. Dominguez (Badalona, Valencia, Barcelona, Bellaterra, Spain; Copenhagen, Denmark)
| |